In both cardiac and non-cardiac surgical patients, intensive insulin regimens aimed to achieve tighter blood glucose targets have found to not be beneficial and confer a high risk of hypoglycemia and increased glucose variability and hence not recommended. The gene discussed is INS; the disease is Hypoglycemia.